Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cemiplimab in Incurable NUT Carcinoma
NCT07050186Phase 2Recruiting
- Sponsor
- Northwestern University
- Start
- Aug 2025
- Primary completion
- Nov 2030
- Countries
- 1
01
Overview
A Phase 2 trial of cemiplimab in NUT carcinoma (NC), sponsored by Northwestern University. Started Aug 2025; status: recruiting.
02
Drugs
cemiplimab
03
Conditions
NUT carcinoma (NC)
Beyond the preview
Go deeper on NCT07050186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07050186.